Achilles Therapeutics Ownership | Who Owns Achilles Therapeutics?


OverviewForecastChart

Achilles Therapeutics Ownership Summary


Achilles Therapeutics is owned by 60.10% institutional investors, 6.51% insiders, and 33.38% retail investors. Artal group is the largest institutional shareholder, holding 1.88% of ACHL shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Achilles Therapeutics shares.

ACHL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAchilles Therapeutics60.10%6.51%33.38%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Artal group755.38K1.88%$615.63K
Renaissance547.23K1.35%$623.85K
Acadian asset management191.83K0.47%$218.00K
Ubs group65.70K0.16%$53.55K
Citadel advisors61.39K0.15%$50.03K
Xtx topco26.82K0.07%$30.58K
Virtu financial22.81K0.06%$19.00K
Brave asset management10.00K0.02%$11.40K
Morgan stanley8.93K0.02%$7.28K
Rhumbline advisers4.48K0.01%$5.11K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Artal group755.38K0.02%$615.63K
Brave asset management10.00K0.00%$11.40K
Xtx topco26.82K0.00%$30.58K
Virtu financial22.81K0.00%$19.00K
Renaissance547.23K0.00%$623.85K
Acadian asset management191.83K0.00%$218.00K
Susquehanna group, llp---
Baader bank aktiengesellschaft---
Two sigma investments, lp---
Two sigma securities---

Top Buyers

HolderShares% AssetsChange
Ubs group65.70K-65.70K
Xtx topco26.82K0.00%26.82K
Virtu financial22.81K0.00%1.87K
Artal group755.38K0.02%-
Rhumbline advisers4.48K--

Top Sellers

HolderShares% AssetsChange
Syncona portfolio---11.09M
Bml capital management---4.10M
Fcpm iii services b.v.---2.39M
Redmile group---1.61M
Vestal point capital, lp---1.50M

New Positions

HolderShares% AssetsChangeValue
Ubs group65.70K-65.70K$53.55K

Sold Out

HolderChange
Qube research-73.00
Jpmorgan chase-137.00
Ica group wealth management-400.00
Bank of america corp /de/-1.09K
Global retirement partners-2.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202421-4.55%24,297,978-0.17%601.66%7-12.50%433.33%
Sep 30, 202422-15.38%24,338,9659.69%601.99%8-3-50.00%
Jun 30, 202426-16.13%22,188,649-5.62%551.61%8-55.56%6-25.00%
Mar 31, 20243163.16%23,510,4557.93%581.98%18125.00%8100.00%
Dec 31, 20231911.76%21,782,17010.61%542.23%833.33%4-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index21.59K0.05%-
Blackstone Alternative Multi-Strategy I100.000.00%-

ACHL Ownership FAQ


Who Owns Achilles Therapeutics?

Achilles Therapeutics shareholders are primarily institutional investors at 60.10%, followed by 6.51% insiders and 33.39% retail investors. The average institutional ownership in Achilles Therapeutics's industry, Biotech Stocks , is 63.96%, which Achilles Therapeutics falls below.

Who owns the most shares of Achilles Therapeutics?

Achilles Therapeutics’s largest shareholders are Artal group (755.38K shares, 1.88%), Renaissance (547.23K shares, 1.35%), and Acadian asset management (191.83K shares, 0.47%). Together, they hold 3.70% of Achilles Therapeutics’s total shares outstanding.

Does Blackrock own Achilles Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Achilles Therapeutics.

Who is Achilles Therapeutics’s biggest shareholder by percentage of total assets invested?

Artal group is Achilles Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 755.38K Achilles Therapeutics shares, valued at 615.63K$.

Who is the top mutual fund holder of Achilles Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Achilles Therapeutics shares, with 0.05% of its total shares outstanding invested in 21.59K Achilles Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools